Cannabis Vape Tech Producer Ispire Enters South African Market Via Exclusive Deal With Dank Pack
Ispire Technology partners with Dank Pack to enter South Africa's cannabis market, supplying top-tier vaping products in an exclusive deal.
Worldwide Weed: Cannabis Companies Althea, Rocket Factory Team Up For Premium Dried Flower Launch
Althea partners with Rocket Factory to launch premium cannabis dried flower products in Australia, the UK, and Germany. Launching June 2024.
DEA Rules THCA Is Not Legal Hemp Amid Industry Shake-Up And Farm Bill Debate On Delta-8 THC Prohibition
DEA rules THCA not legal hemp, sparking industry concerns. Congress debates Farm Bill changes. Curaleaf criticizes amendment. Read now!
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.
Canadian Edibles Producer Indiva Reports Modest Q1 Results, Eyes Strong 2024 After Strategic Realignments
Indiva Q1 2024 results show growth in core brands, offsetting losses from Wana and lozenges, boosting market share. Read now!
California’s Corporate Weed Beef: Glass House Withdraws Defamation Suit Against Catalyst Cannabis
Glass House drops defamation lawsuit against Catalyst Cannabis, citing financial instability and harassment threats. Read all details here!
Cannabis Stocks And ETFs Surged On Marijuana Rescheduling News: WTR’s Industry Report Analyzes What’s Behind The Optimism
DOJ proposes reclassifying cannabis to Schedule III. WTR's report highlights market gains and potential industry impacts. Read insights now!
Cannabis Merger Canceled: Nature’s Miracle And Agrify Terminate Agreement Citing Unfavorable Market Conditions
Nature's Miracle and Agrify mutually terminate merger due to market conditions, cancel all agreements without fees to focus on core products.
Cannabis Stocks Rallied After Rescheduling News, Investment Management Firm Co-Founder Discusses Impact And Next Steps
Explore how DOJ's cannabis rescheduling boosts stocks and insights from Emily Paxhia on the industry's future. Read now!
Tilray Launches $250M At-The-Market Program To Boost Acquisitions, Eyes Expansion With U.S. Cannabis Rescheduling
Tilray launches a $250M ATM program to fund strategic acquisitions and leverage U.S. cannabis rescheduling when effective. Read now!